Content about Lipodystrophy

April 3, 2012
Amylin seeks FDA approval for metreleptin

Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

June 6, 2011
Study: Amylin's metreleptin improves diabetes, lipid control among patients

An investigational drug improved diabetes and lipid control in patients with partial lipodystrophy, according to a new study.

December 20, 2010
Amylin's lipodystrophy treatment granted orphan-drug, fast-track designations

Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

November 10, 2010
Egrifta receives regulatory approval

The Food and Drug Administration has approved a drug for treating excess fat development in...

© 2013 Drug Store News. All Rights Reserved.